linsitinib experimental drug candidate treatment various types cancer inhibitor insulin receptor insulinlike growth factor receptor prevents tumor cell proliferation induces tumor cell linsitinib granted orphan drug designation adrenocortical carcinoma march phase ii clinical trials initiated multiple myeloma ovarian cancer hepatocellular carcinoma nsclc subsatisfactory results caused research indications phase iii clinical trial found linsitinib increase survival patients adrenocortical clinical trials antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikilinsitinib